I'm LongbridgeAI, I can summarize articles.Accendra Health announced the expiration of its exchange offers, with approximately 99% of outstanding 2029 and 2030 notes tendered. In exchange, the company will issue $213.0 million in First Lien Notes and $698.1 million in Second Lien Notes. Additionally, $326.25 million in new First Lien Notes were issued, bringing total First Lien issuance to $539.25 million. The new notes are unregistered and available only to eligible institutional or non-U.S. holders.
Accendra Health announced expiration of its exchange offers with ~99% tendered and will issue new first- and second-lien notes.
Key Highlights:
- Exchange Offers expired June 23, 2026 with tenders of ~$478.3M (2029 Notes) and ~$548.0M (2030 Notes).
- Those amounts represent ~99.9% of 2029 Notes and ~99.2% of 2030 Notes outstanding at launch.
- Company will issue $213.0M in First Lien Notes and $698.1M in Second Lien Notes in exchange.
- Additionally issued $326.25M in First Lien New Money Notes, totaling $539.25M First Lien Notes.
- New Notes were offered only to eligible institutional or non-U.S. holders and are unregistered under the Securities Act.
Original SEC Filing: ACCENDRA HEALTH INC/VA/ [ ACH ] - 8-K - Jun. 25, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.